Aller au contenu principal
Profil bibliographique

L. Ranganath

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

373Publications signalées
5590Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Metabolism and Genetic DisordersAmino Acid Enzymes and MetabolismMitochondrial Function and PathologyDiet and metabolism studiesPeroxisome Proliferator-Activated Receptors

Les publications récentes

Accès ouvert 2026 article OpenAlex

Specific knockout of kidney homogentisate 1,2-dioxygenase reveals that local metabolism of tyrosine and homogentisic acid is negligible in alkaptonuria

Dominic A Rutland, Brendan P. Norman, Juliette H. Hughes, Peter J M Wilson et autres

Extreme metabolic phenotypes present unique opportunities to understand the participation of different organs in specific metabolite pathways. One such condition is the inherited metabolic disorder alkaptonuria (AKU), caused by mutations in the gene encoding the homogentisate 1,2-dioxygenase (HGD) enzyme. HGD is expressed …

gb (code pays fourni par la source)

0 citations Human Molecular Genetics
Accès ouvert 2025 article OpenAlex

Identification of novel collagen breakdown products by human osteoclasts in vitro and in vivo

Brendan P. Norman, J.P. Dillon, S Alkharabsheh, Francoise Congues et autres

Abstract Bone resorption involves dissolution of minerals and enzymatic degradation of bone matrix. The primary enzyme is cathepsin K but other proteases including matrix metalloproteinases are involved. Some cathepsin K cleavage products have been partially identified, including cross-linked telopeptides of type I …

gb, jo, ca (code pays fourni par la source)

1 citation JBMR Plus
Accès ouvert 2025 article OpenAlex

Anopheles mosquito survival and pharmacokinetic modeling show the mosquitocidal activity of nitisinone

Lee R. Haines, Anna Trett, Clair Rose, Marcos Sterkel et autres

One approach to interrupting the transmission of insect-borne diseases that is successfully used in veterinary medicine is exploiting the ability of antiparasitic drugs to make vertebrate blood toxic for blood-feeding insects. Recent studies have identified 4-hydroxyphenylpyruvate dioxygenase (HPPD), an enzyme of the …

gb, ar, ch (code pays fourni par la source)

12 citations Science Translational Medicine
Accès ouvert 2025 article OpenAlex

Urinary metabolite model to predict the dying process in lung cancer patients

Séamus Coyle, Elinor Chapman, David M. Hughes, J. Baker et autres

BACKGROUND: Accurately recognizing that a person may be dying is central to improving their experience of care at the end-of-life. However, predicting dying is frequently inaccurate and often occurs only hours or a few days before death. METHODS: We performed urinary metabolomics …

gb, dk (code pays fourni par la source)

5 citations Communications Medicine
Accès ouvert 2025 article OpenAlex

The effects of age and sex on active and passive hip range of motion in individuals with alkaptonuria

Sophie Taylor, Nick Dobbin, Richard Imrich, Jean-Baptiste Arnoux et autres

Purpose To report active and passive hip range of motion (ROM) data for individuals with alkaptonuria (AKU), with consideration for age, sex, and non-AKU comparative data.Materials and Methods Using a cross-sectional study design, 123 patients who had baseline ROM assessed in a …

gb, sk, fr, ca (code pays fourni par la source)

0 citations Disability and Rehabilitation
Accès ouvert 2024 article OpenAlex

An anatomical investigation of alkaptonuria: Novel insights into ochronosis of cartilage and bone

Juliette H. Hughes, Gemma Charlesworth, Amanda Prior, Claire M. Tierney et autres

Ochronotic pigmentation of connective tissue is the central pathological process in the rare metabolic disease alkaptonuria (AKU). Tissue pigmentation in AKU occurs due to unmetabolised homogentisic acid (HGA) in the circulation, caused by an enzyme deficiency in the liver. Ochronotic pigmentation, derived …

gb (code pays fourni par la source)

1 citation Journal of Anatomy
2024 preprint OpenAlex

Nitisinone Attenuates Aortic Stenosis Disease Progression in Patients with Alkaptonuria: An Analysis of the SONIA 2 Study

Callum Bruce, Priyanka Meenamkuzhy-Hariharan, Shahdat Hussain, Antonio Eleuteri et autres

Background and Aim: Alkaptonuria (AKU) is a rare metabolic disorder characterised by the accumulation of homogentisic acid (HGA). Deposition of HGA in the aortic valve leading to progressive aortic stenosis is a serious complication. Nitisinone has been shown to improve morbidity and …

gb, sk (code pays fourni par la source)

0 citations
2024 article OpenAlex

Nitisinone attenuates progression of aortic stenosis in patients with alkaptonuria: an analysis of the SONIA 2 study

China Bruce, Prashant Hariharan, Shazam Hussain, Antonio Eleuteri et autres

Abstract Background/introduction Alkaptonuria (AKU) is a rare metabolic disorder caused by a defective enzyme, resulting in deposition of unmetabolised homogentisic acid in various connective tissues throughout the body (also termed "ochronosis"). Ochronosis of the aortic valve leading to progressive aortic stenosis is …

gb (code pays fourni par la source)

0 citations European Heart Journal
Accès ouvert 2024 preprint OpenAlex

An anatomical investigation of alkaptonuria: Novel insights into ochronosis of cartilage and bone

Juliette H. Hughes, Gemma Charlesworth, Amanda Prior, Claire M. Tierney et autres

1 Abstract Ochronotic pigmentation of connective tissue is the central pathological process in the rare metabolic disease alkaptonuria (AKU). Tissue pigmentation in AKU occurs due to unmetabolized homogentisic acid (HGA) in the circulation, caused by an enzyme deficiency in the liver. Ochronotic …

gb (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 preprint OpenAlex

not-yet-known not-yet-known not-yet-known unknown Nitisinone Attenuates Aortic Stenosis Disease Progression in Patients with Alkaponuria: An Analysis of the SONIA 2 Study

Callum Bruce, Priyanka Meenamkuzhy-Hariharan, Shahdat Hussain, Antonio Eleuteri et autres

Background and Aim: Alkaptonuria (AKU) is a rare metabolic disorder characterised by the accumulation of homogentisic acid (HGA). Deposition of HGA in the aortic valve leading to progressive aortic stenosis is a serious complication. Nitisinone has been shown to improve morbidity and …

gb, sk (code pays fourni par la source)

0 citations
Accès ouvert 2024 preprint OpenAlex

Nitisinone Attenuates Aortic Stenosis Disease Progression in Patients with Alkaponuria: An Analysis of the SONIA 2 Study

Callum Bruce, Priyanka Meenamkuzhy-Hariharan, Shahdat Hussain, Antonio Eleuteri et autres

Background and Purpose: Alkaptonuria (AKU) is a rare metabolic disorder characterised by the accumulation of homogentisic acid (HGA). Deposition of HGA in the aortic valve leading to progressive aortic stenosis is a serious complication. Nitisinone has been shown to improve morbidity and …

gb, sk (code pays fourni par la source)

0 citations
Accès ouvert 2024 article OpenAlex

Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria

L. Ranganath, Milad Khedr, Anna M. Milan, Andrew Davison et autres

INTRODUCTION: Protein nutrition disorder in alkaptonuria (AKU), resulting in increased homogentisic acid (HGA) before nitisinone therapy and increased tyrosine (TYR) during nitisinone therapy, may benefit from dietetic intervention. The aim of this study was to characterise the diet and their effects prospectively …

gb, sk (code pays fourni par la source)

4 citations Nutrients

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.